Rapid Medical Announces Appointment of James Romero as President, Americas

Experienced Neurovascular Device Executive will Lead Commercialization in US, Canada and LATAM

YOKNEAM, Israel & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas. Mr. Romero will oversee the growth and commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in the United States, Canada and Latin America.

Mr. Romero brings 20 years of sales leadership experience for both growth-stage and large medical device companies. He joins Rapid Medical from Medtronic, where he recently served as Vice President of Sales, North America, for the company’s neurovascular division. With his vast knowledge of the stroke market, he led the company through a period of significant growth and transformation, outpacing the market.

“James brings a breadth of experience and depth of knowledge of the neurovascular field that will greatly augment our commercial development,” commented, Ronen Eckhouse, CEO and co-founder of Rapid Medical. “We are planning to launch three products in the US alone this year. As we continue to expand our portfolio across the Americas, James’ understanding of the markets and their dynamics will be an integral part of our success.”

“Rapid Medical’s portfolio of devices provides enhanced control over procedural outcomes and is poised to revolutionize stroke treatment,” adds James Romero, new President, Americas for Rapid Medical. “I am very impressed with the team and the company’s achievements thus far. The future is exciting for Rapid Medical and stroke therapy.”

About Rapid Medical

Rapid Medical is developing game-changing devices for neurovascular treatments. Utilizing novel manufacturing techniques, Rapid Medical’s devices are the first remotely adjustable tools to provide improved control for better procedural outcomes. TIGERTRIEVER™, COMANECI™ and COLUMBUS™/DRIVEWIRE are CE marked for use in Europe and COMANECI™ and DRIVEWIRE are also FDA approved. More information is available at www.rapid-medical.com.